期刊文献+

尾加压素Ⅱ对慢性肺源性心脏病发病作用的探讨 被引量:1

The role of urotensin Ⅱ in the pathogenesis of chronic cor pulmonale
下载PDF
导出
摘要 目的探讨尾加压素Ⅱ(UⅡ)是否参与了慢性肺源性心脏病(简称肺心病)的发病机制。方法选择慢性肺心病患者25例和健康人20例(对照组),用放射免疫法测定血浆UⅡ的水平,超声多普勒测定肺动脉收缩压(PASP)、室间隔厚度(IVS)、右心室前壁厚度(RVAW)和右心室舒张末期内径(RVEDd),观察各组UⅡ的差异性及其与心脏超声指标的相关性。结果与对照组比较,肺心病患者缓解期血浆UⅡ水平[(2.75±1.18)pmol/L比(2.49±0.44)pmol/L]、PASP[(33.65±9.55)mmHg比(15.70±6.90)mmHg]、IVS[(10.84±2.04)mm比(9.32±1.40)mm]、RVAW[(6.56±0.95)mm比(5.21±1.69)mm]和RVEDd[(25.84±6.61)mm比(21.03±2.62)mm]均显著升高(P均<0.05)。肺心病患者在急性加重期以上指标水平较缓解期进一步显著升高[血浆UⅡ水平(3.43±1.04)pmol/L,PASP(65.94±19.14)mmHg,IVS(11.58±1.96)mm,RVAW(8.15±1.49)mm和RVEDd(38.89±9.35)mm](P均<0.05)。肺心病患者血浆UⅡ水平与PASP、RVAW分别呈正相关(r分别为0.648和0.671,P均<0.05)。结论UⅡ可能参与慢性肺心病的发生发展,血浆UⅡ水平可作为慢性肺心病严重程度的指标之一。 Objective To investigate whether urotensin Ⅱ ( UⅡ ) contributes to the pathogenesis of chronic cor pulmonale. Methods Radioimmunoassay was used to measure the plasma UⅡ in 25 patients with chronic cor pulmonale and 20 healthy controls. Ultrasonic doppler was employed to measure the pulmonary artery systolic pressure(PASP) ,thickness of interventricular septum(IVS) ,right ventricular anterior wall( RVAW), and right ventricular end-diastolic diameter (RVEDd). The levels of of UⅡ in chronic car pulmonale group and control group were compared and their correlations with uhrasonographic parameters were analyzed. Results The levels of UII[ (2. 75 ± 1.18)pmol/L vs(2.49 ±0.44) pmol/L] , PASP[(33.65±9.55)mmHg vs(15.70 ±6.90) mm Hg],IVS[(10.84 ±2.04)mm vs(9.32 ± 1.40) mm], RVAW [ ( 6. 56 ± 0. 95 ) mm vs ( 5.21 ± 1.69) mm ] and RVEDd [ (25.84 ± 6. 61 ) mm vs (21.03 ± 2.62)mm ] in patients with stable chronic cor pulmonale were all higher significantly than those in the control group( all P 〈0. 05 ). Meanwhile,the uhrasonographic parameters got worse and UⅡ elevated during acute exacerbation of chronic car pulmonale [ UⅡ ( 3.43 ± 1.04 ) pmol/L, PASP ( 65.94 ± 19. 14) mm Hg, IVS( 11.58 ± 1.96) ram, RVAW ( 8.15 ± 1.49 ) mm and RVEDd ( 38.89 ± 9. 35 ) mm, all P 〈 0. 05 ]. The plasma level of UⅡ was positively correlated with PASP and RVAW( r = 0. 648 and 0. 671 respectivelly, both P 〈 0.05 ) in patients; with chronic cor pulmonale. Conclusions UⅡ may participate in the pathogenesis of chronic cor pulmonale. Measuring the levels of UⅡ may be a promoising meathod to evaluate the severity and follow the progress of chronic cot plumonale.
出处 《中国呼吸与危重监护杂志》 CAS 2007年第6期416-418,共3页 Chinese Journal of Respiratory and Critical Care Medicine
基金 黑龙江省教育厅研究生创新科研项目(编号:YJSCX2007-0090HLJ)
关键词 尾加压素Ⅱ 慢性肺源性心脏病 发病机制 Urotensln Ⅱ Chronic cot pulmonale Pathogenesis
  • 相关文献

参考文献1

二级参考文献28

  • 1Coulouarn Y, Lihrmann I, Jegou S, Anouar Y, Tostivint H,Beauvillain JC, et al. Cloning of the cDNA encoding the urotensinⅡ precursor in frog and human reveals intense expression of the urotensin Ⅱ gene in motoneurons of the spinal cord. Proc Natl Acad Sci USA 1998; 95: 15803-8.
  • 2Ames RS, Sarau HM, Chambers JK, Willette RN, Aiyar NV,Romanic AM, et al. Human urotensin-Ⅱ is a potent vasoconstrictor and agonist for the orphan receptor GPRI4. Nature 1999, 401: 282-6.
  • 3Douglas SA, Tayara L, Ohlstein EH, Halawa N, Giaid A. Congestive heart failure and expression of myocardial urotensin Ⅱ. Lancet 2002; 359: 1990-7.
  • 4Johns DG, Ao Z, Naselsky D, Herold CL, Maniscalco K, Sarov-Blat L, et al. Urotensin-Ⅱ-mediated cardiomyocyte hypertrophy:effect of receptor antagonism and role of inflammatory mediators.Naunyn Schmiedebergs Arch Pharmacol 2004; 370: 238-50.
  • 5Egginger JG, Camus A, Calas A. Urotensin-Ⅱ expression in the mouse spinal cord. J Chem Neuroanat 2006; 31: 146-54.
  • 6Zhang YG, Qi YF, Xia CF, Pang YZ, Yang J, Zhang ZK, et al.Stimulating proliferation of aorta smooth muscle cells of rat byurotensin Ⅱ. Chin Pharmacol Bull 2001; 17: 155-7.
  • 7Shi L, Ding W, Li D, Wang Z, Jiang H, Zhang J, et al. Proliferation and anti-apoptotic effects of human urotensin Ⅱon human endothelial cells. Atherosclerosis 2006; 188: 260-4.
  • 8Watanabe T, Suguro T, Kanome T, Sakamoto Y, Kodate S,Hagiwara T, et al. Human urotensin II accelerates foam cell formation in human monocyte-derived macrophages. Hypertension 2005; 46: 738-44.
  • 9Russell FD, Molenaar P. Investigation of signaling pathways that mediate the inotropic effect of urotensin-Ⅱ in human heart. Cardiovasc Res 2004; 63:673-81.
  • 10Gruson D, Rousseau MF, Ahn SA, van Linden F, Ketelslegers JM. Circulating urotensin Ⅱ levels in moderate to severe congestive heart failure: Its relations with myocardial function and well established neurohormonal markers. Peptides 2006; 27: 1527- 31.

共引文献35

同被引文献13

  • 1富路,戴颖楠,朱立群,万晓京,曹君娴,韩颖,谢荣盛.慢性心功能衰竭患者血浆尾加压素Ⅱ、内皮素和肾上腺髓质素的变化[J].中国动脉硬化杂志,2007,15(3):201-204. 被引量:9
  • 2Russell FD. Russell urotensin Ⅱ in cardiovascular regulation [ J ]. Vasc Health Risk Manag,2008,4( 4 ) : 775 -785.
  • 3Colon JM, Yano K, Waugh D, et al. Distribution and molecular forms of urotensin Ⅱ and its role in cardiovascular regulation in vertebrates[ J]. J Exp Zool, 1996,275 (2 - 3 ) :226 - 238.
  • 4Douglas SA, Tayara L, Ohlstein EH,et al. Congestive heart failure and expression of myocardial urotensin Ⅱ [ J ]. Lancet, 2002,359 ( 9322 ) : 1990 - 1997.
  • 5Lapp H, Boerrigter G, Costello - Boerrigter LC, et al. Elevated plasma human urotensin - Ⅱ - like immunoreactivity in ischemic cardiomyopathy [ J ]. Int J Cardiol,2004,94 ( 1 ) :93 - 97.
  • 6Nakayama T, Hirose T, Totsune K, et al. Increased gene expression of urotensin Ⅱ - related peptide in the hearts of rats with congestive heart failure[ J]. Peptides ,2008,29(5 ) :801 - 808.
  • 7Jolda -Mydlowska B, Salomon P, Mazurek W. Plasma urotensin Ⅱ level in patients with chronic congestive heart failure [ J ]. Pol Arch Med Wewn,2006,116(6) :1125 - 1136.
  • 8沈晓明,王卫平.儿科学[M].7版.北京:人民卫生出版社,2008:449-450.
  • 9尚利宏,岳少杰.抗生素序贯疗法治疗婴幼儿重症肺炎疗效观察[J].新乡医学院学报,2007,24(6):606-607. 被引量:11
  • 10张一梅,刘温娟,石玉枝,高宇飞,王丽玲,陈铭新.慢性栓塞性肺动脉高压大鼠肺动脉重塑与尾加压素Ⅱ及其受体的表达[J].中华结核和呼吸杂志,2008,31(1):37-41. 被引量:5

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部